Additional ASCO GI 2026 analyses focused on adenoma recurrence, a validated surrogate endpoint in colorectal cancer prevention research
(c) anthropometric measurements, such as body weight, BMI, waist circumference (WC), waist-to-hip ratio, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT)
No, they are not the same, but they are in the same class of drugs
Patients receiving GLP-1s or other weight loss medications often report feeling fuller longer after meals and experiencing fewer urges to snack throughout the day
When GLP-1 is secreted from L-cells through the TGR5 agonist, it stimulates GLP-1R in enterochromaffin cells and induces serotonin or 5-hydroxytryptamine (5-HT) secretion from these cells